Purpose
|
XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, exhibiting >50-fold selectivity over JAK1, JAK3 and TYK2. Phase 1.
|
Characteristics
|
Target: JAK inhibitor, PDGFR inhibitor, FLT3 inhibitor, c-Kit inhibitor Receptor: JAK2,PDGFRβ,JAK1,FLT3,c-Kit Status: Experimental
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
100?%
|
Formula
|
C25H28N6O2
|
Solubility
|
DMSO 16 mg/mL,Water <1 mg="" ml="" <="" td="">
1> |